3rd Berlin Conference on IP in Life Sciences: Effective Life Cycle Management

Effective Life Cycle Management (LCM) is a critical factor for successful commercialisation of pharmaceutical R&D output. This conference offers a unique opportunity to gain insight in the portfolio planning strategies of pharmaceutical companies.

Leading European life science experts from pharma/biotech business and research, contract research, IP and regulatory authorities will share their experience at the conference, which was tailored specifically for decision makers.

Moderation: Dr. Claire Skentelbery, Secretary General, European Biotechnology Foundation, Brussels